Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention
Jinyi Shan,Ziyi Cao,Siming Yu
DOI: https://doi.org/10.2147/ijgm.s490049
IF: 2.145
2024-11-28
International Journal of General Medicine
Abstract:Jinyi Shan, 1 Ziyi Cao, 2 Siming Yu 3 1 School of Graduate Studies, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China; 2 The First Clinical Medical College of Shaanxi, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, People's Republic of China; 3 Nephropathy Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, People's Republic of China Correspondence: Siming Yu, Email Diabetic kidney disease (DKD) is a form of kidney damage resulting from diabetes and represents a common, severe complication of the disease. Globally, DKD is a leading cause of chronic kidney disease (CKD). DKD occurs in both type 1 and type 2 diabetes patients, with early clinical manifestations including microalbuminuria and hypertension. As the condition progresses, symptoms such as massive proteinuria, hypoalbuminemia, and severe edema may appear. The key to treating DKD lies in controlling blood glucose and blood pressure, reducing proteinuria, and slowing the deterioration of kidney function. Acupuncture, a traditional Chinese medicine treatment, has shown some therapeutic effects on DKD through mechanisms such as regulating blood glucose, improving renal blood flow and microcirculation, antioxidation and anti-inflammation, and modulating gut microbiota. Keywords: diabetic kidney disease, acupuncture, mechanism, progress Diabetic kidney disease (DKD) is kidney damage resulting from microvascular complications of diabetes, characterized by excessive urinary albumin excretion, diabetic glomerulopathy, and a decrease in estimated glomerular filtration rate (eGFR). 1 DKD, a prevalent and severe complication of diabetes, is considered to be related to metabolic changes in the body and is a major cause of chronic kidney disease (CKD) worldwide. 2 Despite current treatments, progressive kidney damage may be inevitable or irreversible, and many patients with diabetic nephropathy may still progress to end-stage renal disease (ESRD). 3 DKD is seen in both type 1 diabetes (T1D) and type 2 diabetes (T2D). Acupuncture demonstrates significant advantages in the treatment of DKD. First, it exerts therapeutic effects through multiple mechanisms, not only enhancing insulin sensitivity but also improving renal hemodynamics, increasing kidney blood flow and microcirculation, and reducing intraglomerular hypertension. Additionally, acupuncture's antioxidant and anti-inflammatory properties help mitigate oxidative stress and inflammation induced by hyperglycemia, thereby protecting renal cells and slowing disease progression. Moreover, compared to pharmacological treatments, acupuncture as a non-drug intervention presents fewer side effects and is better tolerated by patients, especially those with multiple comorbidities or limitations in medication use. Acupuncture also regulates the nervous and endocrine systems, providing a multi-targeted approach that improves the overall health of patients. This holistic nature makes acupuncture uniquely advantageous for personalized treatment and enhancing patients' quality of life. In summary, acupuncture not only addresses the pathological mechanisms of DKD from various angles but also stands out in clinical practice due to its high safety profile and broad applicability, making it a promising complementary therapy for comprehensive DKD management. DKD affects 20–50% of diabetic patients, 4 occurring in approximately 40% of diabetes patients. 5 In 2019, 2.6 million new cases of DKD were reported worldwide, and this incidence is expected to rise in the future. 6 By 2030, the global number of diabetes patients may reach around 439 million. 7 According to the latest reports from 2024 literature, Among T1D and T2D patients, 23% to 36% of T1D patients and about 38% of T2D patients will develop DKD. 8 Both forms of diabetes cause quantitative and qualitative differences in kidney damage; for example, typical nodular fibrosis (Kimmelstiel-Wilson nodules) is mainly seen in T1D, whereas glomerular hypertrophy is predominantly observed in T2D. 9 Although the prevalence of T1D and T2D is similar in men and women globally, 10 there are gender differences in the impact of diabetes on end-organ complications, such as DKD. 11 Specifically, female diabetes patients have higher mortality rates and higher prevalence of DKD risk factors such as hypertension, hyperglycemia, obesity, and dyslipidemia. However, the evidence on gender differences in DKD prevalence and disease progression is limited and inconsistent. While many studies suggest that women have a reduced protective effect against renal disease progression in the context of diabetes, -Abstract Truncated-
medicine, general & internal